[go: up one dir, main page]

HK1068501B - Pdgf-bb for the treatment of parkinson's disease - Google Patents

Pdgf-bb for the treatment of parkinson's disease Download PDF

Info

Publication number
HK1068501B
HK1068501B HK05101145.7A HK05101145A HK1068501B HK 1068501 B HK1068501 B HK 1068501B HK 05101145 A HK05101145 A HK 05101145A HK 1068501 B HK1068501 B HK 1068501B
Authority
HK
Hong Kong
Prior art keywords
cells
pdgf
vegf
cell
receptor
Prior art date
Application number
HK05101145.7A
Other languages
English (en)
French (fr)
Chinese (zh)
Other versions
HK1068501A1 (en
Inventor
Kioumars Delfani
Ann Marie Janson
Georg H. Kuhn
Karlheinz Plate
Anne Schanzer
Frank-Peter Wachs
Ming Zhao
Original Assignee
Newron Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newron Sweden Ab filed Critical Newron Sweden Ab
Priority claimed from PCT/IB2002/003998 external-priority patent/WO2003024478A1/en
Publication of HK1068501A1 publication Critical patent/HK1068501A1/en
Publication of HK1068501B publication Critical patent/HK1068501B/en

Links

Claims (4)

  1. Humanes PDGF-BB zur Verwendung bei der Behandlung der Parkinson-Krankheit oder von Parkinson-Syndromen bei einem Patienten durch intraventrikuläre Infusion.
  2. Humanes PDGF-BB zur Verwendung nach Anspruch 1, in einer Menge von 0,1 ng/kg/Tag bis 1 µg/kg/Tag.
  3. Humanes PDGF-BB zur Verwendung nach Anspruch 1, in einer Menge von 0,5 ng/kg/Tag bis 500 ng/kg/Tag.
  4. Humanes PDGF-BB zur Verwendung nach Anspruch 1, wobei das Medikament die Differenzierung, Migration, Proliferation oder das Überleben von Nervenstammzellen oder Nervenvorläuferzellen in dem Patienten bewirkt.
HK05101145.7A 2001-09-19 2002-09-19 Pdgf-bb for the treatment of parkinson's disease HK1068501B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US32338101P 2001-09-19 2001-09-19
US60/323,381 2001-09-19
US32604401P 2001-09-28 2001-09-28
US60/326,044 2001-09-28
PCT/IB2002/003998 WO2003024478A1 (en) 2001-09-19 2002-09-19 Treatment of central nervous system disorders by use of pdgf or vegf

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
HK11108470.9A Division HK1154341A (en) 2001-09-19 2005-02-12 Pdgf for use in the treatment of central nervous system disorders
HK11106377.7A Division HK1152243B (en) 2001-09-19 2005-02-12 Vegf for use in the treatment of central nervous system disorders

Related Child Applications (2)

Application Number Title Priority Date Filing Date
HK11108470.9A Addition HK1154341A (en) 2001-09-19 2005-02-12 Pdgf for use in the treatment of central nervous system disorders
HK11106377.7A Addition HK1152243B (en) 2001-09-19 2005-02-12 Vegf for use in the treatment of central nervous system disorders

Publications (2)

Publication Number Publication Date
HK1068501A1 HK1068501A1 (en) 2005-04-22
HK1068501B true HK1068501B (en) 2013-05-31

Family

ID=

Similar Documents

Publication Publication Date Title
EP1443955B1 (de) Pdgf-bb zur behandlung von morbus parkinson
AU2002334327A1 (en) Treatment of central nervous system disorders by use of PDGF or VEGF
US8318704B2 (en) Modulation of neural stem cells and neural progenitor cells
US20040038888A1 (en) Functional role and potential therapeutic use of PACAP, VIP and Maxadilan in relation to adult neural stem or progenitor cells
Prieto et al. Gas6, a ligand for the receptor protein-tyrosine kinase Tyro-3, is widely expressed in the central nervous system
US20030165485A1 (en) Functional role and potential therapeutic use of Reelin, Gas6 and Protein S in relation to adult neural stem or progenitor cells
Giacobini et al. Hepatocyte growth factor acts as a motogen and guidance signal for gonadotropin hormone-releasing hormone-1 neuronal migration
US20050003998A1 (en) Therapeutic use of selective LXR modulators
Bribian et al. A novel role for anosmin‐1 in the adhesion and migration of oligodendrocyte precursors
US20070149439A1 (en) Pituitary adenylate cyclase-activating polypeptide (PACAP) is an anti-mitogenic signal for selected neuronal precursors in vivo
AU2006203260B2 (en) Treatment of Central Nervous System Disorders by Use of PDGF or VEGF
US8481486B2 (en) Methods of treating neurological diseases by regulating migration of neuroblasts in the adult nervous system with tenascin-R
HK1068501B (en) Pdgf-bb for the treatment of parkinson's disease
HK1152243B (en) Vegf for use in the treatment of central nervous system disorders
HK1154341A (en) Pdgf for use in the treatment of central nervous system disorders
Williams The cellular and molecular changes occurring in the degenerating and regenerating olfactory system
EP1871407A2 (de) Zusammensetzung mit wnt-3-peptid zur modulierung medial-lateraler nerventopographiekarten